As pharma DTC platforms continue to expand, regulators will keep an eye on how discounted drugs are sold — and even advertised — in ways that don’t violate anti-kickback laws.
The 2026 Winter Olympics were defined by a number of factors: the U.S. claiming a record 12 gold medals, the unmatched dominance of Norwegian cross country skier Johannes Høsflot Klæbo and the ...
Ardelyx will leverage the LPGA’s predominantly female audience to directly reach the demographic most affected by IBS-C. The 360-degree approach aims to de-stigmatize chronic gastrointestinal issues ...
2025 MM+M Agency 100 honoree Calcium+Company supported Sun’s campaign, which also featured partners Skin Cancer Champions, AIM at Skin Cancer and the Skin Cancer Foundation. Soleno is running its ad ...
FDA truncates drug approval process; Makary pushes for more OTC drugs; Inside the rocky ride for Recursion Pharmaceuticals.
This article is part of a Rare Disease series sponsored by DeepIntent. With Rare Disease Month wrapping up and Rare Disease Day taking place on Saturday, MM+M is celebrating a handful of campaigns ...
In a letter that cited ProPublica’s reporting, Sens. Rick Scott and Kirsten Gillibrand asked Secretary Pete Hegseth for more information about the military’s drug supply and its reliance on foreign ...
Trump’s surgeon general pick to face Senate health committee; Novo Nordisk to slash GLP-1 prices in 2027; Hims & Hers reassures investors despite drug compounding crackdown.
In a letter that cited ProPublica’s reporting, Sens. Rick Scott and Kirsten Gillibrand asked Secretary Pete Hegseth for more information about the military’s drug supply and its reliance on foreign ...
As U.S. hospitals face an increasing risk of encountering measles, and pressure to immediately spot it, health care workers face an unusual barrier: Many don’t know what it looks like.
The launch of Under Every Hat There’s a Comeback coincides with the release of Nutrafol Men 50+, a hair growth supplement formulated specifically for men over 50. The new product and national campaign ...
Blackstone Life Sciences announced a research and development funding agreement to advance the clinical development of bleximenib, an investigational oral menin inhibitor, for acute myeloid leukemia ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results